TC-6499

DRUG2 trials

Sponsors

Targacept Inc.

Conditions

GastroparesisIrritable Bowel Syndrome

Phase 1

Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis

CompletedNCT02187094

Targacept Inc.Gastroparesis

Start: 2014-06-30End: 2015-01-31Updated: 2015-05-12

Phase 2

Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS)

CompletedNCT01149200

Targacept Inc.Irritable Bowel Syndrome

Start: 2010-05-31End: 2010-10-31Updated: 2013-12-02